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Observations have been reported which suggest that altered electrophoretic
patterns of the serum proteins may accompany pregnancies that terminate in the
birth of abnormal offspring . The teratogenic disazo dye, trypan blue, has been
shown to cause alterations in the proteins of the maternal serum of pregnant
rabbits and in the protein composition of the 9-day rabbit embryo yolk sac
fluid (1,2,3) . These papers report a significant increase in the alpha and
beta globulins . An "abnormal" protein band has been reported in male rats
treated with heavy doses of trypan blue (4,5) . This "abnormal" protein band
was subsequently shown to represent an alteration in a normally occurring alpha
çlobulin component of rat serum (6,7) . Evidence has been presented that serum
proteins of the fetal rat are altered when the mother is treated with a
teratogenic dose of trypan blue (6) . Significant differences are reported
between control and experimental fetuses in beta 4lobulins, alpha-1 olobulins
and albumin .
Abnormal electrophoretic patterns of serum proteins have keen reported in
human pregnancies (S) . An abnormal outcome was observed in 78% of those women
exhibiting an abnormal electrophoretic pattern of serum proteins at same time
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during pregnancy . On the other hand, of the pregnancies showing normal s®rum
proteins, only 1398 terminated abnormally .
The present experiment was undertaken in an effort to determine if alpha
and beta serum globulins can affect the outcome of pregnancy .
Methods
Virgin females of Gristar Albino rats (Albino Farms, Red Sank, fd .J .) were
used in this study . The animals were maintained on a Rockland Complete Rat
Diet ad libitum . Day 0 of pregnancy was considered to begin on the morning
sperm was found in the vaginal smear. Rats received a teratogenic dose of
trypan blue durinç the 8th day of pregnancy (14 mg of dye per 100 gm body wt) .
Forty-eight hours later the rats were exsanguinated and the serum pooled for
subsequent fractionation by a commercial laboratory . Samples for control serum
were obtained from non-treated 10-day pregnant rats .
A sample of each alpha and beta fraction was subjected to paper
electrophoresis to test its purity . Alpha globulin fractions were about 75%
pure and beta globulin fractions about 9096 pure . Colorimetric determinations
of the samples from trypan blue treated pregnant rats revealed the alpha
globulin fraction contained 0.06 mg of trypan blue per 100 gm sample and the
beta globulin fraction 0.04 mg per 100 gm sample . The globulin fractions were
prepared in saline for injection into rats during the 8th day of gestation .
The dose administered (150 mg of alpha globulin ; 100 mg of beta globulin) was
calculated to approximately double the normal physiological amount of globulin
present in a 250 am rat during the 8th day o~ pregnancy (142 mg of alpha
globulins ; 110 mg of beta globulins) .
At the timé~" of intracardiac injection a volume of blood was withdrawn from
the recipient rat equal io the volume of globulin solution to be injected
(1 .5 ml ) . Forty-eight hours after injection blood was withdrawn and serum
obtained . Blood r."as açain drawn on the 20th day just prior to autopsy . The
serum was analyzed èy tae Spinco paper elec~~rop.~oresis system . T~Ze relative
Vol . 4, No. 14
	
SERUM PROTEINS AND TERAZbGENESIB 1355
concentration of each component was determined in the Spinco Analytrol . Total
protein content of the serum was measured with a Bausch and Lomb Serum Protein
Meter . Fetuses obtained at autopsy were examined for the presence of
malformations .
Results
Table I summarizes the fate of rats receiving injections of alpha and beta
serum globulins . Globulins from untreated rats were well tolerated . On the
other hand, globulins from pregnant rats treated with trypan blue caused a high
maternal mortality . Embryonic resorption occurred in all treated groups,
although no fetal malformations were observed .
TABLE I
Effect of intracardiac injection of alpha and beta serum globulins into











control alpha 9 2 73 4 0
globulin
trypan blue 1c 3 90 3 0
alpha çlobulin
control beta 7 1 79 1 G
Globulin
trypan clue a i; 4~ 3 0
beta globulin
untreated 13 0 lE2 2 0
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Table II presents the values for the concentration of serum globulins and
albumin, as well as, total protein concentration in untreated pregnant rats and
in pregnant rats treated with serum globulins . Inspection of the results
suggest a reduction in total protein and albumin following administration of
beta globulins derived from trypan blue treated pregnant rats . A statistical
analysis was not done because of the low number surviving the treatment .
Gamma, alpha, and beta globulins were unaffected . Injections of beta globulins
from untreated pregnant rats or alpha globulins from treated or untreated rats,
did not alter total proteins or serum components beyond the expected normal
range .
Conclusions
Treatment of pregnant rats with serum alpha and beta globulins derived
from trypan blue treated pregnant rats did not cause malformations in the
offspring . The number of resorptions was only slightly increased by this
treatment . Since electrophoresis showed the samples to be relatively free
from contamination we can assume that the altered alpha and beta globulins
cannot, in themselves, be responsible for the induction of malformations in
developing rat fetuses . Information currently available suggests that the
altered serum proteins are a secondary manifestation of the effects of trypan




such varied insults as whole body x-irradiation (g) and vitamin deficiency
(10), the results of this paper do not lend support to the theses that a
causal relation exists between altered serum proteins and abnormal development .
The lowering of total proteins observed following injection of beta
from trypan blue treated pregnant rats is also known to occur
administration of the teratogenic disazo dyes as well as following
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